Cellular localization of mitochondria contributes to Kv channel-mediated regulation of cellular excitability in pulmonary but not mesenteric circulation.
Mitochondria are proposed to be a major oxygen sensor in hypoxic pulmonary vasoconstriction (HPV), a unique response of the pulmonary circulation to low oxygen tension. Mitochondrial factors including reactive oxygen species, cytochrome c, ATP, and magnesium are potent modulators of voltage-gated K(+) (K(v)) channels in the plasmalemmal membrane of pulmonary arterial (PA) smooth muscle cells (PASMCs). Mitochondria have also been found close to the plasmalemmal membrane in rabbit main PA smooth muscle sections. Therefore, we hypothesized that differences in mitochondria localization in rat PASMCs and systemic mesenteric arterial smooth muscle cells (MASMCs) may contribute to the divergent oxygen sensitivity in the two different circulations. Cellular localization of mitochondria was compared with immunofluorescent labeling, and differences in functional coupling between mitochondria and K(v) channels was evaluated with the patch-clamp technique and specific mitochondrial inhibitors antimycin A (acting at complex III of the mitochondrial electron transport chain) and oligomycin A (which inhibits the ATP synthase). It was found that mitochondria were located significantly closer to the plasmalemmal membrane in PASMCs compared with MASMCs. Consistent with these findings, the effects of the mitochondrial inhibitors on K(v) current (I(Kv)) were significantly more potent in PASMCs than in MASMCs. The cytoskeletal disruptor cytochalasin B (10 microM) also altered mitochondrial distribution in PASMCs and significantly attenuated the effect of antimycin A on the voltage-dependent parameters of I(Kv). These findings suggest a greater structural and functional coupling between mitochondria and K(v) channels specifically in PASMCs, which could contribute to the regulation of PA excitability in HPV.
Firth
Amy L
AL
Department of Pharmacy and Pharmacology, University of Bath, Bath, UK. s.v.smirnov@bath.ac.uk
Gordienko
Dmitri V
DV
Yuill
Kathryn H
KH
Smirnov
Sergey V
SV
D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D002462:Cell Membrane / Q000378:metabolism / Q000648:ultrastructure; D008274:Magnesium / Q000378:metabolism; D008297:Male; D008638:Mesenteric Arteries / Q000378:metabolism* / Q000648:ultrastructure*; D008856:Microscopy, Fluorescence; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000648:ultrastructure; D032389:Myocytes, Smooth Muscle / Q000378:metabolism / Q000648:ultrastructure; D009840:Oligomycins / Q000494:pharmacology; D024642:Potassium Channels, Voltage-Gated / Q000187:drug effects / Q000378:metabolism*; D011651:Pulmonary Artery / Q000378:metabolism* / Q000648:ultrastructure*; D011652:Pulmonary Circulation / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D012519:Sarcoplasmic Reticulum / Q000648:ultrastructure; D013152:Splanchnic Circulation / Q000502:physiology
D009840:Oligomycins; D024642:Potassium Channels, Voltage-Gated; D000968:Antimycin A; D008274:Magnesium